Decrease of PECAM-1-gene-expression induced by proinflammatory cytokines IFN-γ and IFN-α is reversed by TGF-β in sinusoidal endothelial cells and hepatic mononuclear phagocytes by Neubauer, Katrin et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BMC Physiology
Open Access Research article
Decrease of PECAM-1-gene-expression induced by 
proinflammatory cytokines IFN-γ and IFN-α is reversed by TGF-β in 
sinusoidal endothelial cells and hepatic mononuclear phagocytes
Katrin Neubauer, Alexander Lindhorst, Kyrylo Tron, Giuliano Ramadori and 
Bernhard Saile*
Address: University of Göttingen, Department of Internal Medicine, Section of Gastroenterology and Endocrinology, Göttingen, Germany
Email: Katrin Neubauer - kneubau@gwdg.de; Alexander Lindhorst - alindho@gwdg.de; Kyrylo Tron - ktron@gwdg.de; 
Giuliano Ramadori - gramado@med.uni-goettingen.de; Bernhard Saile* - bsaile@gwdg.de
* Corresponding author    
Abstract
Background and aim: The mechanisms of transmigration of inflammatory cells through the
sinusoids are still poorly understood. This study aims to identify in vitro conditions (cytokine
treatment) which may allow a better understanding of the changes in PECAM (platelet endothelial
cell adhesion molecule)-1-gene-expression observed in vivo.
Methods and results: In this study we show by immunohistochemistry, that there is an
accumulation of ICAM-1 (intercellular cell adhesion molecule-1) and ED1 positive cells in necrotic
areas of livers of CCl4-treated rats, whereas there are few PECAM-1 positive cells observable.
After the administration of CCl4, we could detect an early rise of levels of IFN-γ followed by an
enhanced TGF-β protein level. As shown by Northern blot analysis and surface protein expression
analysed by flow cytometry, IFN-γ-treatment decreased PECAM-1-gene-expression in isolated
SECs (sinusoidal endothelial cells) and mononuclear phagocytes (MNPs) in parallel with an increase
in ICAM-1-gene-expression in a dose and time dependent manner. In contrast, TGF-β-treatment
increased PECAM-1-expression. Additional administration of IFN-γ to CCl4-treated rats and
observations in IFN-γ-/- mice confirmed the effect of IFN-γ on PECAM-1 and ICAM-1-expression
observed in vitro and increased the number of ED1-expressing cells 12 h after administration of
the toxin.
Conclusion: The early decrease of PECAM-1-expression and the parallel increase of ICAM-1-
expression following CCl4-treatment is induced by elevated levels of IFN-γ in livers and may
facilitate adhesion and transmigration of inflammatory cells. The up-regulation of PECAM-1-
expression in SECs and MNPs after TGF-β-treatment suggests the involvement of PECAM-1 during
the recovery after liver damage.
Background
Inflammatory cells leave the circulation at sites of local
inflammation through a series of distinct sequential steps
that are classified as rolling, activation, tight adhesion,
transmigration and passage across the basement mem-
brane [1-6]. Due to the specialized sinusoids, inflamma-
Published: 8 May 2008
BMC Physiology 2008, 8:9 doi:10.1186/1472-6793-8-9
Received: 13 November 2007
Accepted: 8 May 2008
This article is available from: http://www.biomedcentral.com/1472-6793/8/9
© 2008 Neubauer et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
Page 2 of 14
(page number not for citation purposes)
tory processes in the liver are thought to differ from those
in other organs. It has been suggested that SECs of the nor-
mal liver – in contrast to capillary endothelial cells – only
express a restricted set of adhesion molecules [7-9].
PECAM-1 is known to be expressed on the surface of
endothelial cells, circulating platelets, monocytes, granu-
locytes and some subsets of T-lymphocytes. PECAM-1 has
been proposed as one of the main players in transend-
othelial migration of neutrophils, monocytes, and natural
killer cells in both in vivo and in vitro models, since by the
use of antibodies directed against PECAM-1, transmigra-
tion and inflammation could be significantly reduced [10-
12]. However, the pathomechanisms involving PECAM-1
are still a matter of debate, since in a PECAM-1-knock-out-
mouse model, transmigration of inflammatory cells and
inflammatory damage were almost unchanged [13].
In our previous studies, we have demonstrated that
PECAM-1 is expressed in SECs and MNPs of the rat liver.
Furthermore, we have shown that the PECAM-1 expres-
sion in SECs and MNPs is decreased after CCl4-treatment
in vivo before inflammatory phagocytes accumulate in the
pericentral area of rat livers and following IFN-α-treat-
ment of cultured SECs and MNPs in vitro. In contrast,
ICAM-1-gene expression is upregulated early after CCl4
administration, reaching a maximum after 24 h. Thereaf-
ter, ICAM-1 is decreasingly expressed in SECs, reaching
the control level of the value at 0 h after 48–72 h. In MNPs
ICAM-1 is maximally expressed 6 h after CCl4 administra-
tion and thereafter expression declines to control levels 72
h after CCl4 administration. [14,15].
Since we have seen that there is a down-regulation of
PECAM-1 in the rat liver after the administration of CCl4,
in this study we aimed to identify further cytokines that
are responsible for the down-regulation of PECAM-1 on
SECs and on transmigrating mononuclear phagocytes
(MNPs), but also to identify cytokines that allow the
reversal of this effect on both cell types.
A pivotal role in pathomechanisms of liver injury has
been assigned to IFN-γ next to IFN-α [16] and it has been
demonstrated that IFN-γ can induce IFN-α expression in
MNPs [17]. TGF-β is a known pleiotropic cytokine with
profibrogenic and anti-inflammatory capacities [18]. In
this study we measured the concentration of IFN-γ and
TGF-β in the rat liver at different time points after CCl4-
administration paying particular attention to the early
time points. Furthermore we tested the modulation of
PECAM-1 and ICAM-1-expression in SECs and MNPs fol-
lowing IFN-γ-treatment in vitro and in vivo. We also stud-
ied the effect of TGF-β on PECAM-1 expression in isolated
SECs and MNPs. Whereas IFN-γ reduces PECAM-1 expres-
sion in parallel with the increase of ICAM-1 expression,
TGF-β up-regulates both molecules and is also able to
counteract the down-regulating effect of IFN-γ on PECAM-
1 expression in vitro.
These data strongly suggest an early down-regulation of
PECAM-1 in parallel to an ICAM-1 up-regulation as a pos-
sible important mechanism for the adhesion and transmi-
gration of inflammatory cells. However, further in vitro
and in vivo studies are required to confirm this hypothe-
sis. The TGF-β induced PECAM-1 up-regulation may be of
importance during the recovery phase.
Results
PECAM-1-immunoreactivity in livers from normal rats and 
from rats treated with CCl4: Comparison to ED1-, and 
ICAM-1-immunoreactivity
Immunostaining of sections from a normal rat liver using
a monoclonal antibody against rat PECAM-1 revealed
positivity along the sinusoids in a similar pattern to
ICAM-1 (Figure 1), suggesting PECAM-1 positivity of
SECs. Staining of sequential sections by antibodies against
PECAM-1 and against markers of MNPs (ED1) suggests
that the positivity along the sinusoids of the normal rat
liver is also partly due to MNPs (Figure 1).
To analyze PECAM-1 immunoreactivity under conditions
of inflammation, we used a model of CCl4-induced liver
damage, which is characterized by the accumulation of
inflammatory cells (mostly MNPs) starting 12 h after the
administration of CCl4 and peaking after 48 h, when peri-
central necrotic areas can be seen. The possibility that
some PECAM-1 positive cells are myofibroblasts (MFB),
activated HSCs (hepatic stellate cells), or liver myofibrob-
lasts deriving from cells different from quiescent HSCs can
be excluded since isolation of these cell types at different
time points after CCl4 administration and primary cul-
tures of HSC or liver myofibroblasts from normal rat liv-
ers never showed any PECAM-1-gene expression (data not
shown).
At 48 h after a single dose of CCl4 there were significant
numbers of ICAM-1 and ED1 positive cells within the
necrotic pericentral areas (Figure 1). However, the ICAM-
1- and ED1-immunoreactive cells of the necrotic area were
PECAM-1 negative (Figure 1).
Expression of IFN-γ, IFN-α and TGF-β in CCl4-treated rat 
livers
During recent years, an important role for IFN-γ and TGF-
β in acute and chronic liver damage has been suggested
(for review see [19-21]). Since we aimed to identify
cytokines responsible for the modulation of PECAM-1
and ICAM-1 in vivo, we measured the concentrations of
IFN-γ and TGF-β protein in liver homogenates after a sin-
gle CCl4-administration using EIA or Elisa. Compared toBMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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Indirect immunodetection of PECAM-1, ICAM-1, and ED1 in sections of normal rat or acutely damaged livers (48 h after a sin- gle CCl4-administration) Figure 1
Indirect immunodetection of PECAM-1, ICAM-1, and ED1 in sections of normal rat or acutely damaged livers 
(48 h after a single CCl4-administration). Sections of normal rat liver tissue (a, c, e) or acutely damaged rat liver tissue (b, 
d, f) were stained with a monoclonal antibody directed against rat PECAM-1 (a, b), ICAM-1 (c, d), ED1 (e, f), followed by the 
APAAP immunodetection (Original magnification × 250). Figures 1g and 1h are the negative control, which was performed 
with murine serum. Note that in the necrotic areas around the central vein most of the ED1-positive cells representing inflam-
matory MNPs are PECAM-1 negative, but ICAM-1 positive.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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the livers of untreated controls (time point 0 h), there was
an early steep increment in IFN-γ expression with a maxi-
mum 9 h after CCl4 administration, reaching a level of 46
pg per mg of liver wet weight. At 24 h after CCl4 adminis-
tration the IFN-γ concentration peaked at the level of the
control livers. At 96 h after CCl4 administration the IFN-γ
expression returned to the level seen in the livers of
untreated rats. (Figure 2). TGF-β expression only slightly
increased during the first 12 h after CCl4-administration.
However it increased significantly thereafter with a maxi-
mum after 72 h, reaching a level of 67 pg per mg of liver
wet weight and returned to the level seen in the livers of
untreated rats after 96 h (Figure 2).
Since measurement of cytokine levels in over the whole
liver gave no information on possible local variations in
concentration we performed Western Blot analysis of p-
STAT1 and p-SMAD2/3 in SECs isolated at different time
points after CCl4 administration. p-STAT1 was found to be
increased at 12 h and 24 h after CCl4
-administration, indi-
cating that a receptor-mediated IFN signal transduction
lasts longer than suspected from the cytokin levels of the
total liver. In order to investigate at which time points
after CCl4-administration TGF-β induces intracellular sig-
naling in SECs we performed Western Blot analysis of p-
SMAD2/3. Whereas TGF-β expression is increased
between 24 h and 72 h after CCl4-administration, p-
SMAD2/3 is decreased in SECs isolated 24 h–48 h after
CCl4-administration. Thereafter p-SMAD2/3 is found to
be increased.
IFN-γ decreases PECAM-1 transcript level in liver SECs and 
MNPs
We analysed the modulation of the PECAM-1 specific
transcript level in cultured SECs and MNPs following
treatment with IFN-γ (Figure 3). SECs at day one after iso-
lation were cultured in the absence or presence of IFN-γ
under serum reduced conditions (0.3% FCS). Testing dif-
ferent concentrations of IFN-γ (100, 1000, 10000 U/ml)
indicated that the strongest effects of IFN-γ on the
PECAM-1 transcript level were found at a concentration of
10000 U/ml. As shown in Figure 3A, IFN-γ causes a
decrease in the PECAM-1 specific transcript level. In con-
trast the ICAM-1 mRNA level in SECs was increased by
IFN-γ-treatment. Furthermore, different stimulation peri-
ods (4 h, 8 h, 12 h, and 24 h of incubation with IFN-γ)
were compared indicating maximal effects on PECAM
specific transcripts after 8 to 12 h of stimulation. It is note-
worthy, that an increase of ICAM-1 and a parallel decrease
of PECAM-1 could already be observed after 4 h of treat-
ment (Figure 3B) suggesting that the regulation of the two
genes may take place at the same time.
Since we were interested in the modulation of PECAM-1
by IFN-γ not only on SECs but also on the transmigrating
MNPs, we also tested MNPs. In MNPs from normal rat liv-
ers at day 1 after isolation cultured in the absence or pres-
ence of IFN-γ (100, 1000, 10000 U/ml) a maximal
decrease of PECAM-1 specific transcripts was revealed
using 10000 U/ml of IFN-γ for 12 h. At the same time the
(A) Expression of TNF-α, IFN-γ, and TNF-β during acute  liver damage (CCl4-model) Figure 2
(A) Expression of TNF-α, IFN-γ, and TNF-β during 
acute liver damage (CCl4-model). Livers taken at differ-
ent time points after a single administration of CCl4 were 
homogenized and used with a human-TNF-α and human-
TNF-β EIA-kit or rat-IFN-γ ELISA-kit. Cytokine concentra-
tion is indicated as pg per mg of liver wet weight. Error bars 
indicate standard deviation of the mean value of four experi-
ments from four different animals. (B) Western Blot analysis 
of p-SMAD2/3 and p-STAT-1 in SECs during acute liver dam-
age (CCl4-model). SECs from untreated control rats (c) and 
different time points after CCl4 administration were isolated. 
β-actin was used as loading control (not shown). Consistent 
data could be shown in SECs isolated from two different rats 
for each time point.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
Page 5 of 14
(page number not for citation purposes)
(A) IFN-γ decreases PECAM-1 transcript level and elevates the ICAM-1 transcript level in liver SECs or MNPs Figure 3
(A) IFN-γ decreases PECAM-1 transcript level and elevates the ICAM-1 transcript level in liver SECs or MNPs. 
Northern blot analysis of total RNA extracted from primary cultures of SECs or MNPs at 24 h after isolation either untreated 
(0 h) or treated with IFN-γ (1000 (103) or 10000 (104) U/ml) for 12 h. Five µg of total RNA was separated on agarose gel, blot-
ted and hybridised with a 32P-dCTP-labeled cDNA probe specific for rat PECAM-1. Same membranes were hybridised with a 
cDNA specific for rat ICAM-1 or for β- and γ-actin. This figure shows results of five experiments from five different isolations. 
The lower panel shows a statistical evaluation of densitometric scans. Error bars indicate standard deviation of the mean value 
after normalization on β,γ-actin expression. The P-value was tested to show significant differences of control cells compared to 
cells treated with IFN-γ. * indicates p < 0.05. (B) Northern blot analysis of total RNA extracted from primary cultures of SECs 
at day 1 after isolation treated with IFN-γ (1000 U/ml) for 4 h, 8 h, 12 h or 24 h. Five µg of total RNA was separated on agar-
ose gel, blotted and hybridised with a 32P-dCTP-labeled cDNA probe specific for rat PECAM-1. The same membranes were 
hybridised with a cDNA specific for rat ICAM-1 or for β- and γ-actin. (c) The untreated control. The lower panel shows a sta-
tistical evaluation of densitometric scans. Error bars indicate standard deviation of the mean value normalized on β,γ-actin 
expression of five experiments from five different isolations of each cell type. P-value was tested to show significant differences 
of control cells compared to cells treated with IFN-γ. * indicates p < 0.05.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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ICAM-1 mRNA level was increased in MNPs following
IFN-γ-treatment (Figure 3A).
TGF-β-treatment increases PECAM-1 transcript level in 
cultured SECs and MNPs from normal rat livers
Since we had noted the TGF-β levels increasing during the
recovery phase of CCl4 induced liver injury, we wanted to
analyze whether TGF-β could have reverse effects on
PECAM-1-expression compared to IFN-γ. When SECs or
MNPs were cultured in the presence of TGF-β for different
time periods (4 h, 8 h, 12 h, and 24 h) a maximal increase
of PECAM-1 specific transcript level was reached after 12
h to 24 h of stimulation. In addition, cells were treated
with TGF-β in different concentrations (1, 3 and 10 ng/
ml) for 12 hours under serum reduced conditions (0.3%
FCS). While no effect of TGF-β on the PECAM-1 mRNA-
level was detectable at a concentration of 1 ng/ml, treat-
ment with TGF-β at a concentration of 3 or 10 ng/ml
resulted in an increased PECAM-1 specific transcript level
in SECs and in MNPs (Figure 4). The strongest effects were
revealed using 10 ng/ml of TGF-β. An increase of ICAM-1
specific transcript levels was observed in SECs following
the treatment with TGF-β. There was no significant
increase in ICAM-1 specific transcript level in MNPs.
In order to investigate whether TGF-β is capable of revers-
ing the effect of IFN-γ on PECAM-1 and ICAM-1 expres-
sion on SECs or MNPs or whether both cytokines simply
have inverse but independent effects we additionally cul-
tured SECs or MNPs with IFN-γ and TGF-β. Northern Blot
TNF-β increases the PECAM-1 transcript level and ICAM-1 transcript level in liver SECs and MNPs Figure 4
TNF-β increases the PECAM-1 transcript level and ICAM-1 transcript level in liver SECs and MNPs. Northern 
blot analysis of total RNA extracted from primary cultures of SECs or MNPs at day 1 after isolation either untreated (c) or 
treated with TNF-β for 24 h (in a concentration of 1, 3 and 10 ng/ml). Five µg of total RNA was separated on agarose gel, blot-
ted and hybridised with a 32P-dCTP-labeled cDNA probe specific for rat PECAM-1. The same membranes were hybridised 
with a cDNA specific for rat ICAM-1 or for β- and γ-actin. This figure shows results for five experiments from five different 
isolations. The lower panel shows a statistical evaluation of densitometric scans. Error bars indicate standard deviation of the 
mean value normalized on β,γ-actin expression of five experiments from five different isolations of each cell type. P-value was 
tested to show significant differences of control cells compared to cells treated with TNF-β. * indicates p < 0.05.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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TNF-β reverses the effect of IFN-γ on PECAM-1 transcript level but has no additional effect on the ICAM-1 transcript level in  liver SECs and MNPs Figure 5
TNF-β reverses the effect of IFN-γ on PECAM-1 transcript level but has no additional effect on the ICAM-1 
transcript level in liver SECs and MNPs. Northern blot analysis of total RNA extracted from primary cultures of SECs 
and MNPs at day 1 after isolation either untreated (c) or treated with IFN-γ 10000 (104)U/ml (I) or IFN-γ together with TNF-
β (10 ng/ml) (I+T) for 12 h. Five µg of total RNA was separated on agarose gel, blotted and hybridised with a 32P-dCTP-labeled 
cDNA probe specific for rat PECAM-1. The same membranes were hybridised with a cDNA specific for rat ICAM-1 or for β- 
and γ-actin. This figure shows results of five experiments from five different isolations. The lower panel shows a statistical eval-
uation of densitometric scans. Error bars indicate standard deviation of the mean value after normalization on β,γ-actin expres-
sion. P-value was tested to show significant differences of control cells compared to cells treated with IFN-γ or IFN-γ +TNF-β. 
* indicates p < 0.05.
analysis revealed that coadministration of IFN-γ and TGF-
β inhibits the PECAM-1-downregulating effect of IFN-γ on
both cell types. On the other hand coadministration of
both cytokines had no additional effect on upregulation
of ICAM-1 (Figure 5).
Surface expression of PECAM-1 and ICAM-1 on SECs and 
MNPs following IFN-α-, IFN-γ – or TGF-β-treatment
To demonstrate that IFN-γ – or TGF-β treatment also influ-
ences PECAM-1 and ICAM-1 surface expression, we fur-
ther investigated the PECAM-1-gene-expression in SECs
and MNPs following treatment with IFN-γ or TGF-β by
flow cytometry.
SECs and MNPs were isolated from rat livers and taken in
culture for 24 h, cultured in the presence or absence of
IFN-γ or TGF-β for 12 h and processed for flow cytometry.
In accordance with the data from the Northern blot anal-
ysis, IFN-γ treatment reduced the PECAM-1-expression in
both SECs and MNPs (Figure 6) and at the same time
induced the expression of ICAM-1, whereas TGF-β-treat-
ment increased PECAM-1- and ICAM-1-expression onBMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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SECs. On MNPs only an insignificant increase in ICAM-1
expression was observed.
Constant PECAM-1 specific transcript level in CCl4-
treated IFN-γ-/- mice livers and reduced increase of the 
ICAM-1 specific transcript level
For a functional proof that IFN-γ leads to an early decrease
of PECAM-1 and to an early increase of ICAM-1 specific
transcripts in vivo we used an IFN-γ-/- mice knockout
model (B6.129S7-Ifngtm1Ts) [22]. In control mice
(female C57BL mice), similar CCl4-administration levels
to those previously used in rats leads to an early decrease
of PECAM-1 specific transcripts and to an increase of
ICAM-1 specific transcripts. Whereas an increase of ICAM-
1 specific transcripts can also be observed in IFN-γ-/- mice
livers after CCl4-administration, no significant decrease of
PECAM-1 specific transcripts was evident (Figure 7A). A
histological comparison after inducing acute liver damage
by CCl4 showed that the degree of damage in the IFNγ-/-
mice was less than in the control mice. Furthermore the
damaged pericentral areas were smaller, less fatty and the
occurrence of necrotic areas, which were also smaller in
the liver sections from IFNγ-/- mice, was observed later (48
h vs. 24 h after CCl4 administration). Even 72 h after CCl4
administration the hepatocytes are more vital (Fig. 7B).
Treatment of rats with IFN-γ enhances the decrease of 
PECAM-1-gene-expression in CCl4-treated rat livers in 
parallel to an enhanced increase of the ICAM-1 gene-
expression
To further analyse whether the effects of IFN-γ observed in
vitro in the previous experiments can be reproduced in
vivo, rats were treated either with CCl4 or with IFN-γ and
CCl4 in parallel. Measurement of the IFN-γ concentration
in liver homogenates by means of ELISA revealed an
increase of 5–10% in the IFN-γ concentration in liver tis-
sue following the intraperitoneal treatment with 50000 U
IFN-γ. Since, from the in vitro and in vivo experiments we
expected the effects of IFN-γ within the first 10 h after
treatment, livers were analyzed (3 h, 6 h, 12 h after treat-
ment) for changes in PECAM-1 and ICAM-1-gene-expres-
sion by Northern blot analysis (Figure 8).
When rats were treated with IFN-γ and CCl4 the increase of
ICAM-1 transcript level and the decrease of PECAM-1
transcript level was enhanced compared to rats treated
with CCl4 alone. This difference between rats treated with
CCl4 and IFN-γ to rats treated with CCl4 alone was only
detectable up to 6 h following the treatment.
Treatment of rats with IFN-γ enhances the accumulation 
of ED1-expressing cells in CCl4-treated rat livers
Since differences in adhesion molecule expression follow-
ing the additional treatment with IFN-γ could be observed
up to 6 h after treatment, sections of rat livers were ana-
lysed by indirect immunostaining with a monoclonal
antibody against the ED1 antigen at 3 h, 6 h, and 12 h
after the treatment to analyze whether the amount of
recruited inflammatory cells was influenced. The staining
of control livers revealed the previously observed pattern
of non-parenchymal cells situated around the vessels. At
12 h after CCl4-treatment the number of ED1-positive
cells around the vessels and along the sinusoids increased.
Interestingly, when rats were treated with the combina-
tion of IFN-γ and CCl4 the number of ED1 positive cells at
12 h was significantly higher than in the livers of animals
treated with CCl4 alone (Figure 9).
Discussion
Since we have seen that there is a down-regulation of
PECAM-1 in rat livers after the administration of CCl4, in
this study we aimed to identify cytokines that were
responsible for the down-regulation of PECAM-1 on SECs
and on transmigrating MNPs, but we also wanted to iden-
tify cytokines that allow the reversal of this effect on both
cell types. In this study, we show that in CCl4-treated rat
livers there is an early rise of levels of IFN-γ and – during
the recovery phase – an increase of TGF-β-protein level.
Similar observations for TGF-β levels after induced liver
damage have also been reported by others [23,24]. How-
ever especially measurements of the early time points are
missing in the literature. This might be the reason for
reports of a decrease of IFN-γ after inducing liver damage
Surface expression of PECAM-1 and ICAM-1 in SECs and  MNPs under the treatment of TNF-β or IFN-γ Surface  expression of PECAM-1 and ICAM-1 in SECs Figure 6
Surface expression of PECAM-1 and ICAM-1 in SECs and 
MNPs under the treatment of TNF-β or IFN-γ Surface 
expression of PECAM-1 and ICAM-1 in SECs.isolated from 
control rats taken for 1 day in culture under the treatment of 
TNF-β 10(ng/ml) or IFN-γ 1000 U/ml) for the last 12 h. Error 
bars indicate standard deviation of the(mean value (n = 4). P-
value was tested to show significant differences of control 
cells compared to cells treated with IFN-γ or TNF-β. * indi-
cates p < 0.05.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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(A) HE staining of liver sections of C57BL/6 mice (a, c, e, g, i) and B6 Figure 7
(A) HE staining of liver sections of C57BL/6 mice (a, c, e, g, i) and B6.129S7-Ifngtm1Ts (IFN-γ-/-) mice (b, d, f, h, k). 
Sections of normal livers (a, b) or acutely damaged livers (after a single CCl4-administration) at time points 12 h (c, d), 24 h (e, 
f), 48 h (g, h) and 72 h (i, k) are given. (B) Lack of decrease of PECAM-1 specific transcript level in CCl4-treated IFN-γ-/- mice liv-
ers and reduced increase of the ICAM-1 specific transcript level. C57BL/6 mice (controls) and B6.129S7-Ifngtm1Ts (IFN-γ-/-) 
mice were treated with CCl4 and livers were taken for analysis 3 h (3 h), 6 h (6 h) or 12 h (12 h) after treatment (each time 
point two animals). (c) The untreated control. 10 µg of total RNA was separated on agarose gel, blotted and hybridised with a 
32P-labeled cDNA probe specific for mouse PECAM-1. β,γ-actin was used as loading control. This figure shows results for 2 
experiments of two animals sacrificed at each time point.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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[25]. In vitro studies indicated that IFN-γ-treatment
induced a decrease of PECAM-1-gene-expression in paral-
lel with an increase in ICAM-1-gene-expression. Further-
more, TGF-β-treatment resulted in an increase of PECAM-
1-expression in SECs and MNPs. TGF-β – also inhibited
the effect of IFN-γ treatment. However, the temporal
course of the cytokine expression in vivo after administra-
tion of the damaging noxae does not perfectly match the
temporal course of changes in the expression of PECAM-1
or ICAM-1. This has two major causes. Firstly, in vivo,
many intercellular contacts and additional cytokines have
an impact on PECAM-1 and ICAM-1 expression on SECs
and MNPs e.g. IFN-α [15] which shows a similar expres-
sion profile compared to IFN-γ. Secondly, local differ-
ences in the concentration of the cytokines can lead to
increased levels of the cytokines around SECs or MNPs
when levels in the total liver are already decreased. The
observation that IFN-γ or TGF-β signalling as measured by
p-STAT1 or p-SMAD2/3 is delayed and can be observed
when the levels of IFN-γ or TGF-β are already decreasing
supports this thesis.
The in vitro effect of IFN-γ could be confirmed in vivo,
since the administration of IFN-γ (0,4 µg per mg liver wet
weight, which is comparable to the concentration used for
the in vitro treatment (0.01 to 0.1 µg/ml of IFN-γ)),
together with CCl4 further decreased the PECAM-1 tran-
script level and also further increased the number of ED1-
positive cells in the liver at 12 h after the administration
of CCl4 compared to the single CCl4 administration to the
animals. In contrast, in IFN-γ-/- mice the lack of IFN-γ may
be responsible for the missing early decrease of PECAM-1
and the reduced increase of ICAM-1.
To study the involvement of cell adhesion molecules dur-
ing inflammation and tissue damage in vivo several
Treatment of rats with IFN-γ enhances the number of ED1  positive cells Figure 9
Treatment of rats with IFN-γ enhances the number 
of ED1 positive cells. Animals were treated with CCl4 or 
with CCl4 and IFN-γ and livers were taken for analysis 3 h (3 
h), 6 h (6 h) or 12 h (12 h) after treatment. Sections were 
stained by indirect immunohistochemistry using a mono-
clonal antibody against ED1. Positive cells were counted in 
10 purviews (250 × magnification). Error bars indicate stand-
ard deviation of the mean value of 10 counted purviews. P-
value was tested to show significance differences of rats 12 h 
after treatment with CCl4 compared to treatment with CCl4 
and IFN-γ. * indicates p < 0.05.
Treatment of rats with IFN-γ enhances the decrease of the  PECAM-1 specific transcript level in CCl4-treated rat livers in  parallel to an enhanced increase of the ICAM-1 specific tran- script level Figure 8
Treatment of rats with IFN-γ enhances the decrease 
of the PECAM-1 specific transcript level in CCl4-
treated rat livers in parallel to an enhanced increase 
of the ICAM-1 specific transcript level. Animals were 
treated with CCl4 (-) or with CCl4 and IFN-γ (+) and livers 
were taken for analysis 3 h (3 h), 6 h (6 h) or 12 h (12 h) after 
treatment (each time four animals). (c) The untreated con-
trol. 10 µg of total RNA was separated on agarose gel, blot-
ted and hybridised with a 32P-labeled cDNA probe specific 
for rat PECAM-1. The same membranes were hybridised 
with a cDNA specific for rat ICAM-1 or for β- and γ-actin. 
This figure shows the results for four experiments. The 
lower panel shows a statistical evaluation of densitometric 
scans. Error bars indicate standard deviation of the mean 
value normalized on β,γ-actin expression of five experiments 
from five different isolations of each cell type. P-value was 
tested to show significant differences of rats 12 h after treat-
ment with CCl4 compared to treatment with CCl4 and IFN-γ. 
* indicates p < 0.05.BMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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approaches have been used. It has been difficult to block
inflammation using reagents directed against single mol-
ecules. Several studies, however, revealed that the transmi-
gration of monocytes and of neutrophils could be
inhibited using antibodies against PECAM-1 in vitro [12],
and in vivo, as the administration of antibodies against
PECAM-1 or the administration of the soluble domain 1
of PECAM-1 blocked the accumulation of leukocytes in
different models of inflammation [10,11,26,27]. In
PECAM-1-knock-out-mice, however, only a slowing of
inflammatory cells transmigrating through the basement
membrane was observed. This slowing had no effect on
the total number of transmigrated cells [13].
In vivo data showing a reduced PECAM-1 expression in
inflammatory cells have been interpreted as if PECAM-1
down-regulation were a consequence of the transmigra-
tion [28]. Our results demonstrate that in vitro and in vivo
treatment with IFN-γ down-regulates the expression of
PECAM-1 in liver cells at an early time point. The in vitro
studies reveal a decreased PECAM-1-expression on SECs
and on MNPs. These data support the hypothesis that
PECAM-1 has to be down-regulated to facilitate transmi-
gration. A confirmation of this hypothesis could be seen
in a model of abdominal aortic transplantation. The
transmigration of MNPs was unexpectedly enhanced
when aortic allografts from PECAM-1 knock-out-mice
were transplanted compared to transplanted allografts
from wild type mice [29]. The authors suggested that this
phenomenon might be due to the fact that PECAM-1 is
concentrated at interendothelial junctions and is thereby
important for the structural stability of the endothelial
barrier. In PECAM-1 deficient grafts this endothelial sta-
bility could be reduced during the inflammatory episode
after transplantation making it easier for macrophages to
transmigrate through the endothelium.
Another relevant finding of the in vivo experiments is the
increase of TGF-β concentration in the liver during the
recovery phase after CCl4-administration, when IFN-γ –
and IFN-α concentration have already been decreased.
TGF-β is a pleiotropic cytokine with profibrogenic and
anti-inflammatory capacities [18]. The data presented in
this study show that in cultured SECs and MNPs, TGF-β
increases PECAM-1-expression. Furthermore, TGF-β
inhibited the effect of IFN-γ on the PECAM-1 transcript
level. Although an up-regulation of PECAM-1-gene-
expression by TGF-β-treatment has been observed using a
human macrophage cell line (U937 cells) [30], this is the
first report showing similar effects on endothelial cells
and on tissue macrophages. These data indicate a different
modulation of PECAM-1 by IFN-γ and TGF-β in SECs and
MNPs. Under normal conditions SECs are an efficient bar-
rier against corpusculate matter. Early production of IFN-
γ after administration of toxic agents could not only
induce an increase of ICAM-1 expression, but also a
decreased PECAM-1 expression, which is essential for the
tight adhesion and for the transmigration of inflamma-
tory cells into the parenchyma. During liver repair
cytokines such as TGF-β may be effective in reestablishing
the endothelial barrier.
Whereas IFN-γ has previously been shown to exert antifi-
brotic effects in man and mice by abrogating TGF-β signal-
ling [31,32], inducing an acute liver damage in IFN-γ
knockout mice revealed that the degree of damage was
reduced and delayed when compared to control mice.
This suggests that, least in the early time points after
administration of a damaging noxae, IFN-γ is involved in
an increase of liver damage without antagonizing TGF-β.
From these data, blockage of IFN-γ signalling in the early
time points after liver damage, thereby inhibiting down-
regulation of PECAM, could be a valuable tool in the treat-
ment of patients during the early phases of liver damage.
Methods
Animals
Male Wistar rats (8 weeks old) (Charles River, Sulzberg,
Germany), female C57BL/6 mice and B6.129S7-
Ifngtm1Ts (IFN-γ-deficient) mice (The Jackson Labora-
tory, Bar Harbor, ME) received humane care and were
kept according to the institution's and the National Insti-
tutes' of Health guidelines.
Reagents
Human recombinant IFN-γ was purchased from R&D sys-
tems (Wiesbaden, FRG). Human TGF-β and IFN-α were
purchased from Sigma (Deistendorfen, FRG). The mono-
clonal antibody against rat PECAM-1 was purchased from
Natutec (Frankfurt, FRG). The monoclonal antibodies
against rat ICAM-1 was from Genzyme (Cambridge, MA,
USA), against pSTAT1, pSMAD2/3 and β-actin were from
Santa Cruz Biotechnology (Heidelberg, Germany) and
against ED1 was from Biermann (Biermann, Wiesbaden,
Germany).
cDNA probes
Rat and mouse PECAM-1 and ICAM-1 specific cDNAs
were generated as described earlier [14,15]. Northern blot
results were normalised to an oligonucleotide probe spe-
cific for 28S rRNA [33] or with a chicken α-actin cDNA
exhibiting cross reactivity with β- and γ-actin, which was a
gift from A. Schwartz [34]. Furthermore, a PCR-generated
cDNA directed against rat IFN-α was used mapping posi-
tions 140–509 of the published sequence [35].
Inducing liver damage
Acute liver damage was induced in 8 weeks old male Wis-
tar rats (body weight about 200 g) by oral administration
of a carbon-tetrachloride/maize oil solution (50% v/v) asBMC Physiology 2008, 8:9 http://www.biomedcentral.com/1472-6793/8/9
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described [36-38]. Control animals were treated with
maize-oil only. Six animals in each group were sacrificed
3 h, 6 h, 9 h, 12 h, 24 h, 48 h, 72 h, and 96 h after a single
high dose CCl4 administration. Furthermore, 16 animals
were treated with IFN-γ (50000 IU/100 g body weight
which is about 0.4 µg per mg of rat liver, assuming that
about 80% of the intraperitoneally injected IFN-γ reaches
the liver) in addition to CCl4-treatment. Animals were sac-
rificed 3 h, 6 h, 12 h, and 24 h after the treatment, since
we expected IFN-γ induced modulation of gene expres-
sion to take place at early time points after the administra-
tion. For inducing liver damage in mice a carbon-
tetrachloride/maize oil solution (50% v/v) was adminis-
trated intraperitoneally with a concentration of 1 ml
CCl4/kg.
Immunohistology
APAAP-immunostaining was performed as described
[39]. Negative controls were performed by replacing the
primary antibody by murine IgGs. ED1 positive cells were
counted in 10 purviews (250 × magnification) of immu-
nostainings of two independent series of experiments.
Measurement of IFN-γ, IFN-α and TGF-β in liver tissue
Liver specimens (40 mg) were homogenized and used
with a human-IFN-α and-TGF-β EIA-kit (Chemicon, Tam-
emcula, USA) or rat-IFN-γ ELISA-kit (Genzyme Diagnos-
tics, Cambridge, Massachusetts, USA). Measurements
were carried out according to the manufacturers' proto-
cols.
Cell isolation and culture conditions
MNPs from normal rat livers were isolated according to
the method of De Leeuw et al. [40] as described previously
[41]. SECs from normal rat livers were obtained according
to Knook et al. [42] with modifications as described
[14,15,36]. MNPs were cultured in M-199 supplemented
with 10% FCS. SECs were cultured on collagen-coated tis-
sue culture plates in endothelial cell medium (Promo cell,
Heidelberg, FRG) supplemented with epidermal growth
factor (10-11 mg/ml), basic fibroblast growth factor (10-9
mg/ml), 0.15% insulin and 2% FCS. The medium was
replaced every day. Purity of SECs was more than 91% as
tested by incorporation of dioctadecyl tetramethyl indo-
carbocyanine perchlorate acetylated low density lipopro-
tein and electron microscopy of SECs as described in
[14,15,43]. Freshly isolated MNPs from normal livers
were more than 99% viable and more than 98% pure (as
tested by ED1/ED2 staining). On day 1 of culture, SECs
and MNPs were washed three times with Gey's balanced
salt solution and were incubated in serum reduced (0.3%
FCS) culture medium with increasing concentrations of
IFN-α (10, 100, 1000, U/ml), IFN-γ (10, 100, 1000,
10000 U/ml which is 0.01 to 0.1 µg/ml), or TGF-β (1, 3,
and 10 ng/ml).
Flow cytometric quantification of PECAM-1 and ICAM-1 
expression in isolated liver cells
For quantification of PECAM-1 and ICAM-1 immunoflu-
orescence after indirect immunostaining, we used flow
cytometry of MNPs and SECs on day one after isolation
(Epics ML, Coulter, Kerfeld, Germany). Negative controls
were performed using murine IgGs instead of the primary
antibody.
Northern Blot analysis of total RNA
Total RNA was isolated according to Chirgwin [44] and
was separated by agarose gel electrophoresis, transferred
onto nylon membranes and hybridised with specific 32P
dCTP or 32P dATP labeled cDNA probes as described [43].
cDNA probes were labelled by Random priming®. The
oligo recognizing the 28S rRNA was end labelled using 32P
dATP. Hybridization was carried out over 2 h at 68°C
using the Quick Hyb®  solution. Post hybridization –
washes were performed twice for 15 minutes at room tem-
perature and twice for 5 – 15 minutes at 50°C in 2 × SSC
containing 0.1% SDS. Nylon filters were exposed to X-ray
films at -80° and finally densitometric scans were per-
formed.
Western Blot Analysis
Cells were lysed in hot Laemmli buffer (95°C) and proc-
essed by sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE; 9% polyacrylamide) under
reducing conditions [45]. The protein content of the cell
lysates was calculated by the Coomassie Protein Assay
(Pierce, Rockford, IL) and 30 µg protein per lane were
applied. Proteins were transferred onto Hybond-ECL
nitrocellulose membranes according to [46]. Immunode-
tection was performed according to the ECLWestern blot-
ting protocol. Antibodies against p-STAT1 and p-SMAD2/
3 were used at 2.5 µg/ml solutions, β-actin at 1:1000 solu-
tion, and peroxidase-labeled anti-mouse and anti-rabbit
immunoglobulins were each used at a 1:1000 dilution.
Statistical analysis
Densitometric analysis of the blots was performed using
the program Scion Image Beta 4.0.2 (NIH, Washington,
USA). Statistical evaluation was done by means of the Wil-
coxon test.
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